Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 1
2014 2
2015 6
2016 9
2018 2
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all
Page 1
Nerve Hypertrophy in Primary Amyloidosis.
Rasenack M, Proebstel AK, Athanasopoulou IM, Décard BF, Grimm A. Rasenack M, et al. Muscle Nerve. 2016 Sep;54(3):510-2. doi: 10.1002/mus.25113. Epub 2016 Apr 28. Muscle Nerve. 2016. PMID: 26999802 No abstract available.
Efficacy and Safety of Fingolimod in an Unselected Patient Population.
Rasenack M, Rychen J, Andelova M, Naegelin Y, Stippich C, Kappos L, Lindberg RL, Sprenger T, Derfuss T. Rasenack M, et al. PLoS One. 2016 Jan 6;11(1):e0146190. doi: 10.1371/journal.pone.0146190. eCollection 2016. PLoS One. 2016. PMID: 26734938 Free PMC article.
Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development.
Meira M, Sievers C, Hoffmann F, Haghikia A, Rasenack M, Décard BF, Kuhle J, Derfuss T, Kappos L, Lindberg RL. Meira M, et al. Among authors: rasenack m. Neurol Neuroimmunol Neuroinflamm. 2016 Mar 31;3(3):e223. doi: 10.1212/NXI.0000000000000223. eCollection 2016 Jun. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27088119 Free PMC article.
Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS.
Zimmermann M, Sanderson NS, Rasenack M, Lalive PH, Lang AB, Curtin F, Lindberg RL, Kappos L, Derfuss T. Zimmermann M, et al. Among authors: rasenack m. Neurol Neuroimmunol Neuroinflamm. 2015 Aug 20;2(5):e144. doi: 10.1212/NXI.0000000000000144. eCollection 2015 Oct. Neurol Neuroimmunol Neuroinflamm. 2015. PMID: 26380353 Free PMC article.
Hepcidin is an antibacterial, stress-inducible peptide of the biliary system.
Strnad P, Schwarz P, Rasenack MC, Kucukoglu O, Habib RI, Heuberger D, Ehehalt R, Müller MW, Stiehl A, Adler G, Kulaksiz H. Strnad P, et al. Among authors: rasenack mc. PLoS One. 2011 Jan 24;6(1):e16454. doi: 10.1371/journal.pone.0016454. PLoS One. 2011. PMID: 21283681 Free PMC article.
Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosis.
Naegelin Y, Rasenack M, Andelova M, Von Felten S, Fischer-Barnicol B, Amann M, Mehling M, Kappos L, Sprenger T, Derfuss T. Naegelin Y, et al. Among authors: rasenack m. Mult Scler Relat Disord. 2018 Oct;25:14-20. doi: 10.1016/j.msard.2018.07.005. Epub 2018 Jul 6. Mult Scler Relat Disord. 2018. PMID: 30014876 Free article.
Effects of different endurance exercise modalities on migraine days and cerebrovascular health in episodic migraineurs: A randomized controlled trial.
Hanssen H, Minghetti A, Magon S, Rossmeissl A, Rasenack M, Papadopoulou A, Klenk C, Faude O, Zahner L, Sprenger T, Donath L. Hanssen H, et al. Among authors: rasenack m. Scand J Med Sci Sports. 2018 Mar;28(3):1103-1112. doi: 10.1111/sms.13023. Epub 2018 Jan 8. Scand J Med Sci Sports. 2018. PMID: 29161767 Clinical Trial.
19 results